|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 22 • Issue 34 • August 22, 2019
|
|
|
Researchers concluded, "In this open-label study, ZYN002 CBD gel was well tolerated and produced clinically and statistically meaningful reductions in anxiety and behavioral symptoms among children and adolescents with FXS.
|
|
|
|
|
|
Regulation and education is a more effective and a more preferable tool to discourage youth use and access than is criminalization.
|
|
|
|
|
|
However, regulators at the US Food and Drug Administration have taken the position that such products cannot legally be marketed as either medicines, food additives, or health supplements.
|
|
|
|
A new study reported that the passage of recreational marijuana laws is associated with an estimated reduction in annual opioid mortality "in the range of 20 to 35 percent, with particularly pronounced effects for synthetic cannabinoids."
|
|
|
|
|
|
Commenting on the findings, one of the study's lead investigators said, "Cannabis offers the average patient an effective alternative to using opioids for general use in the treatment of pain with very minimal negative side effects for most people."
|
|
|
|
Illinois' medical cannabis program is being expanded under new legislation signed into law by Gov. J.B. Pritzer.
|
|
|
|
|
|
Federal Report: Youth Marijuana Use Steadily Declining Details
08/20/19 8:44pm UTC
Arizona NORML, Partners File 2020 Statewide Legalization Initiative Details
08/20/19 6:51pm UTC
What Is the MORE Act, and How Could It Change Marijuana Policy Forever? Details
08/19/19 4:26pm UTC
American Bar Association Endorses Ending Marijuana Prohibition Details
08/13/19 7:31pm UTC
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|